Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 21 November 1997:
Vol. 278. no. 5342, pp. 1462 - 1464
DOI: 10.1126/science.278.5342.1462
Prev | Table of Contents | Next

Reports

Targeting of HIV- and SIV-Infected Cells by CD4-Chemokine Receptor Pseudotypes

Michael J. Endres, * Salman Jaffer, Beth Haggarty, Julie D. Turner, Benjamin J. Doranz, Peter J. O'Brien, Dennis L. Kolson, James A. Hoxie

Retroviral vectors containing CD4 and an appropriate chemokine receptor were evaluated for the ability to transduce cells infected with human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV). These CD4-chemokine receptor pseudotypes were able to target HIV- and SIV-infected cell lines and monocyte-derived macrophages in a manner that corresponded to the specificity of the viral envelope glycoprotein for its CD4-chemokine receptor complex. This approach could offer a way to deliver antiviral genes directly to HIV-infected cells in vivo and could provide an additional treatment strategy in conjunction with existing antiviral therapies.

M. J. Endres, B. Haggarty, J. D. Turner, P. J. O'Brien, J. A. Hoxie, Department of Medicine, Hematology-Oncology Division, University of Pennsylvania, Philadelphia, PA 19104, USA.
S. Jaffer and D. L. Kolson, Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA.
B. J. Doranz, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
*   To whom correspondence should be addressed. E-mail: endres{at}mail.med.upenn.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Inhibition of HIV-1 Infection and Replication by Enhancing Viral Incorporation of Innate Anti-HIV-1 Protein A3G: A NON-PATHOGENIC Nef MUTANT-BASED ANTI-HIV STRATEGY.
L. A. Green, Y. Liu, and J. J. He (2009)
J. Biol. Chem. 284, 13363-13372
   Abstract »    Full Text »    PDF »
Nef Can Enhance the Infectivity of Receptor-Pseudotyped Human Immunodeficiency Virus Type 1 Particles.
M. Pizzato, E. Popova, and H. G. Gottlinger (2008)
J. Virol. 82, 10811-10819
   Abstract »    Full Text »    PDF »
Cell-Free Assay of G-Protein-Coupled Receptors Using Fluorescence Polarization.
J. W. Jones, T. A. Greene, C. A. Grygon, B. J. Doranz, and M. P. Brown (2008)
J Biomol Screen 13, 424-429
   Abstract »    PDF »
Lipid Rafts and Pseudotyping.
W. F. Pickl, F. X. Pimentel-Muinos, and B. Seed (2001)
J. Virol. 75, 7175-7183
   Abstract »    Full Text »
Nef Enhances Human Immunodeficiency Virus Type 1 Infectivity Resulting from Intervirion Fusion: Evidence Supporting a Role for Nef at the Virion Envelope.
J. Zhou and C. Aiken (2001)
J. Virol. 75, 5851-5859
   Abstract »    Full Text »    PDF »
Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics.
C. M. Hogan and S. M. Hammer (2001)
Ann Intern Med 134, 978-996
   Abstract »    Full Text »    PDF »
Properties of Wild-Type, C-Terminally Truncated, and Chimeric Maedi-Visna Virus Glycoprotein and Putative Pseudotyping of Retroviral Vector Particles.
U. Zeilfelder and V. Bosch (2001)
J. Virol. 75, 548-555
   Abstract »    Full Text »
Role of Vif in Stability of the Human Immunodeficiency Virus Type 1 Core.
A. Öhagen and D. Gabuzda (2000)
J. Virol. 74, 11055-11066
   Abstract »    Full Text »
Soluble Receptor-Induced Retroviral Infection of Receptor-Deficient Cells.
R. Damico and P. Bates (2000)
J. Virol. 74, 6469-6475
   Abstract »    Full Text »
N-Linked Glycosylation of CXCR4 Masks Coreceptor Function for CCR5-Dependent Human Immunodeficiency Virus Type 1 Isolates.
D. J. Chabot, H. Chen, D. S. Dimitrov, and C. C. Broder (2000)
J. Virol. 74, 4404-4413
   Abstract »    Full Text »
Retroviral Vector Targeting to Human Immunodeficiency Virus Type 1-Infected Cells by Receptor Pseudotyping.
N. V. Somia, H. Miyoshi, M. J. Schmitt, and I. M. Verma (2000)
J. Virol. 74, 4420-4424
   Abstract »    Full Text »
Incorporation of Wild-Type and C-Terminally Truncated Human Epidermal Growth Factor Receptor into Human Immunodeficiency Virus-Like Particles: Insight into the Processes Governing Glycoprotein Incorporation into Retroviral Particles.
P. Henriksson, T. Pfeiffer, H. Zentgraf, A. Alke, and V. Bosch (1999)
J. Virol. 73, 9294-9302
   Abstract »    Full Text »    PDF »
CD4-Chemokine Receptor Hybrids in Human Immunodeficiency Virus Type 1 Infection.
P. J. Klasse, M. M. Rosenkilde, N. Signoret, A. Pelchen-Matthews, T. W. Schwartz, and M. Marsh (1999)
J. Virol. 73, 7453-7466
   Abstract »    Full Text »
Shift of Clinical Human Immunodeficiency Virus Type 1 Isolates from X4 to R5 and Prevention of Emergence of the Syncytium-Inducing Phenotype by Blockade of CXCR4.
J. A. Esté, C. Cabrera, J. Blanco, A. Gutierrez, G. Bridger, G. Henson, B. Clotet, D. Schols, and E. De Clercq (1999)
J. Virol. 73, 5577-5585
   Abstract »    Full Text »
CXCR4 Sequences Involved in Coreceptor Determination of Human Immunodeficiency Virus Type-1 Tropism. UNMASKING OF ACTIVITY WITH M-TROPIC Env GLYCOPROTEINS.
Z.-x. Wang, J. F. Berson, T.-y. Zhang, Y.-H. Cen, Y. Sun, M. Sharron, Z.-h. Lu, and S. C. Peiper (1998)
J. Biol. Chem. 273, 15007-15015
   Abstract »    Full Text »    PDF »
A biosensor assay for studying ligand-membrane receptor interactions: Binding of antibodies and HIV-1 Env to chemokine receptors.
T. L. Hoffman, G. Canziani, L. Jia, J. Rucker, and R. W. Doms (2000)
PNAS 97, 11215-11220
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)